OGFOD1

Prolyl 3-hydroxylase OGFOD1 · Q8N543 · OGFOD1 on Sugi Atlas →

1,361 patent compounds predicted against OGFOD1, 1,134 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Vadadustat Vadadustat (SCHEMBL1920738) 1.00 1/20
SCHEMBL3419112 SCHEMBL3419112 1.00 1/20
SCHEMBL3421361 SCHEMBL3421361 1.00 1/20
SCHEMBL3422096 SCHEMBL3422096 1.00 1/20
SCHEMBL3422098 SCHEMBL3422098 1.00 1/20
SCHEMBL3423522 SCHEMBL3423522 1.00 1/20
SCHEMBL3703019 SCHEMBL3703019 1.00 1/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL3703018) 0.98 1/20
SCHEMBL3419140 SCHEMBL3419140 0.97 1/20
SCHEMBL3421189 SCHEMBL3421189 0.97 1/20
SCHEMBL3423425 SCHEMBL3423425 0.97 1/20
Bicarbonate Bicarbonate (SCHEMBL15419071) 0.97 1/20
Vadadustat Vadadustat (SCHEMBL1921291) 0.89 1/20
SCHEMBL3419490 SCHEMBL3419490 0.88 1/20
SCHEMBL3419275 SCHEMBL3419275 0.86 1/20
SCHEMBL3422104 SCHEMBL3422104 0.86 1/20
SCHEMBL3424056 SCHEMBL3424056 0.86 1/20
SCHEMBL3424343 SCHEMBL3424343 0.86 1/20
SCHEMBL14980827 SCHEMBL14980827 0.85 1/20
SCHEMBL3418320 SCHEMBL3418320 0.83 1/20

Clinical trials — most relevant to OGFOD1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes PHASE2UNKNOWN
Study of the Effects of Iron on Lung Blood Pressure at High Altitude PHASE2WITHDRAWN
Mitochondrial Function of Immune Cells in Sepsis nanCOMPLETED
Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery nanCOMPLETED
Investigation of Copy Number Variations and Genetic Variants in POI nanRECRUITING
X-Chromosome Inactivation Status and Premature Ovarian Failure nanCOMPLETED
Prospective Genetic Study in Patients With Ovarian Insufficiency nanUNKNOWN
Neurologic Injuries in Adults With Urea Cycle Disorders nanCOMPLETED
Gyrate Atrophy Ocular and Systemic Study nanACTIVE_NOT_RECRUITING
Primary Hyperoxaluria Mutation Genotyping/Phenotyping nanCOMPLETED
Predictors of Outcome of Pediatric Renal Transplantation nanNOT_YET_RECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Drivers of Hypoxia-induced Angiogenesis in Tumor Development nanUNKNOWN
Genetic Determinants of Congenital Heart Disease Outcomes nanCOMPLETED
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer nanRECRUITING
Selecting Hypoxic Tumours for Treatment Modification nanRECRUITING
Study of the Effects of Iron Levels on the Lungs at High Altitude nanCOMPLETED
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Rare Kidney Stone Consortium Biobank nanRECRUITING
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome nanUNKNOWN
Exome Sequencing for Atypical Femoral Fractures nanCOMPLETED
Genetic Analysis of Familial Cases of Premature Ovarian Failure nanCOMPLETED
Hypoxia Inducible factor1-Alpha Genetic Polymorphism of Obstructive Sleep Apnea nanUNKNOWN
Evaluation of Blood Protein O-GlcNAcylation Levels in Children nanRECRUITING
Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism nanCOMPLETED
Role of Polymorphisms in the IL-1 Gene Cluster nanCOMPLETED
International Registry for Primary Hyperoxaluria nanWITHDRAWN
Hemochromatosis and Iron Overload Screening Study (HEIRS) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a OGFOD1 binder may also engage these)

ProteinNameSimilarity
Q5R4R3 1.000 Q5R4R3 →
Q3MI03 1.000 Q3MI03 →
Q3U0K8 1.000 Q3U0K8 →
Q6DE73 1.000 Q6DE73 →
Q9I7H9 0.992 Q9I7H9 →
P40032 0.985 P40032 →
Q11120 0.984 Q11120 →
Q95K79 0.981 Q95K79 →
Q96BT7 0.981 Q96BT7 →
Q80Y20 0.980 Q80Y20 →
KAT8 Histone acetyltransferase KAT8 0.979 landscape →
Q8VIJ5 0.979 Q8VIJ5 →
KDM5B Lysine-specific demethylase 5B 0.979 landscape →
A3KP59 0.978 A3KP59 →
A3KGZ2 0.978 A3KGZ2 →
Q01F03 0.978 Q01F03 →
Q07G10 0.978 Q07G10 →
C3XRY1 0.978 C3XRY1 →
Q5XHF8 0.978 Q5XHF8 →
A1A4L5 0.977 A1A4L5 →
Q09879 0.977 Q09879 →
OGA Protein O-GlcNAcase 0.977 landscape →
Q7K4H4 0.977 Q7K4H4 →
KDM5D Lysine-specific demethylase 5D 0.977 landscape →
Q9QXG2 0.977 Q9QXG2 →
B4GUZ2 0.977 B4GUZ2 →
Q8WUF8 0.977 Q8WUF8 →
A6NC97 0.976 A6NC97 →
Q5K651 0.976 Q5K651 →
Q14AI0 0.976 Q14AI0 →